Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer
Ridho Assidicky(Bilkent University), Özgür Şahin(MUSC Hollings Cancer Center)
Cited by 58
Related Papers
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
|Oncogene|2012|286
Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells
|Cancer Research|2018|131
The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer
|Oncotarget|2016|59
Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers
|Cell Death and Differentiation|2019|53
Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer
|British Journal of Cancer|2020|49